Nadín Fernández-Vega1, José Ramón Ramos-Rodriguez2, Francisco Alfaro2, Miguel Ángel Barbancho2,3, Natalia García-Casares4,5,6,7. 1. Department of Medicine, Faculty of Medicine, University of Málaga, Málaga, España. 2. Centro de Investigaciones Médico-Sanitarias (C.I.M.ES), University of Málaga, Málaga, España. 3. Instituto de Investigación Biomédica de Málaga (I.B.I.M.A), Málaga, España. 4. Department of Medicine, Faculty of Medicine, University of Málaga, Málaga, España. nagcasares@uma.es. 5. Centro de Investigaciones Médico-Sanitarias (C.I.M.ES), University of Málaga, Málaga, España. nagcasares@uma.es. 6. Instituto de Investigación Biomédica de Málaga (I.B.I.M.A), Málaga, España. nagcasares@uma.es. 7. Departamento de Medicina, Facultad de Medicina, Universidad de Málaga, Boulevard Louis Pasteur, 32, C.P 29010, Málaga, España. nagcasares@uma.es.
Abstract
BACKGROUND: Magnetic resonance spectroscopy (MRS) provides non-invasive information about metabolic features in different regions of the brain affected by mesial temporal sclerosis (MTS). PURPOSE: To review articles analyzing the most common alterations in biochemical parameters in MTS and the applications of MRS in presurgical assessment. METHODS: We undertook a systematic literature search for MRS in MTS in PubMed, SCOPUS, and Cochrane based on the MESH terms ""Magnetic Resonance Spectroscopy", "Proton Magnetic Resonance Spectroscopy", "Carbon-13 Magnetic Resonance Spectroscopy", "1H-MRS", "31P-MRS", "mesial temporal sclerosis", "hippocampal sclerosis", "mesial temporal seizure", and "mesial temporal epilepsy". RESULTS: Of the initial 134 articles found, 30 were selected after the exclusion process. Of these, 13 detected a decrease in N-acetylaspartate (NAA), 9 showed a decreased in the ratio NAA/Cho+Cr, and 8 demonstrated a decreased in the ratio NAA/Cr, all of them in the ipsilateral hippocampus. Nine studies also found reduced NAA levels in extrahippocampal regions. CONCLUSIONS: The main findings were a decrease in NAA in the ipsilateral hippocampus. In addition, NAA levels were low outside the hippocampus so MTS could be a more extensive disease. Patients without MTS also presented a decrease in NAA in the ipsilateral hippocampus although NAA was even lower in the MTS patients. Thus, MRS could be useful in the presurgical evaluation to locate the epileptogenic focus, but not specific for the diagnosis of MTS.
BACKGROUND: Magnetic resonance spectroscopy (MRS) provides non-invasive information about metabolic features in different regions of the brain affected by mesial temporal sclerosis (MTS). PURPOSE: To review articles analyzing the most common alterations in biochemical parameters in MTS and the applications of MRS in presurgical assessment. METHODS: We undertook a systematic literature search for MRS in MTS in PubMed, SCOPUS, and Cochrane based on the MESH terms ""Magnetic Resonance Spectroscopy", "Proton Magnetic Resonance Spectroscopy", "Carbon-13 Magnetic Resonance Spectroscopy", "1H-MRS", "31P-MRS", "mesial temporal sclerosis", "hippocampal sclerosis", "mesial temporal seizure", and "mesial temporal epilepsy". RESULTS: Of the initial 134 articles found, 30 were selected after the exclusion process. Of these, 13 detected a decrease in N-acetylaspartate (NAA), 9 showed a decreased in the ratio NAA/Cho+Cr, and 8 demonstrated a decreased in the ratio NAA/Cr, all of them in the ipsilateral hippocampus. Nine studies also found reduced NAA levels in extrahippocampal regions. CONCLUSIONS: The main findings were a decrease in NAA in the ipsilateral hippocampus. In addition, NAA levels were low outside the hippocampus so MTS could be a more extensive disease. Patients without MTS also presented a decrease in NAA in the ipsilateral hippocampus although NAA was even lower in the MTS patients. Thus, MRS could be useful in the presurgical evaluation to locate the epileptogenic focus, but not specific for the diagnosis of MTS.
Authors: Eun Joo Park; Maria Concepción Garcia Otaduy; Katarina Paz de Lyra; Celi Santos Andrade; Luiz Henrique Martins Castro; Valmir Passarelli; Rosa Maria Figueiredo Valerio; Carmen Lisa Jorge; Miriam Harumi Tsunemi; Claudia da Costa Leite Journal: Arq Neuropsiquiatr Date: 2016-02 Impact factor: 1.420
Authors: M T Doelken; G Richter; H Stefan; A Doerfler; A Noemayr; T Kuwert; O Ganslandt; C H Nimsky; T Hammen Journal: AJNR Am J Neuroradiol Date: 2007-03 Impact factor: 3.825
Authors: Regula S Briellmann; R Mark Wellard; Richard A J Masterton; David F Abbott; Samuel F Berkovic; Graeme D Jackson Journal: Epilepsia Date: 2007-02 Impact factor: 5.864
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: PLoS Med Date: 2009-07-21 Impact factor: 11.069
Authors: Jerome Engel; Samuel Wiebe; Jacqueline French; Michael Sperling; Peter Williamson; Dennis Spencer; Robert Gumnit; Catherine Zahn; Edward Westbrook; Bruce Enos Journal: Epilepsia Date: 2003-06 Impact factor: 5.864